NO20053734L - Hundevaksine mor Bordetella Bronchiseptica. - Google Patents
Hundevaksine mor Bordetella Bronchiseptica.Info
- Publication number
- NO20053734L NO20053734L NO20053734A NO20053734A NO20053734L NO 20053734 L NO20053734 L NO 20053734L NO 20053734 A NO20053734 A NO 20053734A NO 20053734 A NO20053734 A NO 20053734A NO 20053734 L NO20053734 L NO 20053734L
- Authority
- NO
- Norway
- Prior art keywords
- leptospira
- bordetella bronchiseptica
- canine
- vaccines
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Foreliggende oppfinnelse angår vaksiner og metoder for beskyttelse av hunder mot sykdom forårsaket av Bordetella bronchiseptica. Foreliggende oppfinnelse angår også kombinasjons-vaksiner og metoder for beskyttelse av hunder mot sykdom eller lidelse forårsaket av hundepatogener, for eksempel infeksiøs trakeobronkitt forårsaket av Bordetella bronchiseptica, hund valpesyke forårsaket av hund valpesyke- (CD) virus, infeksiøs hundehepatitt (ICH) forårsaket av hund adenovirus type 1 (CAV-1), respiratorisk sykdom forårsaket av hund adenovirus type 2 (CAV-2), hund parainfluensa forårsaket av hund parainfluensa- (CPI) virus, enteritt forårsaket av hund coronavirus (CCV) og hund parvovirus (CP V) og leptospirose forårsaket av Leptospira Bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae eller Leptospira pomona. Vaksinene ifølge foreliggende oppfinnelse omfatter et Bordetella bronchiseptica p68 antigen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44341803P | 2003-01-29 | 2003-01-29 | |
PCT/IB2004/000146 WO2004067031A1 (en) | 2003-01-29 | 2004-01-15 | Canine vaccines against bordetella bronchiseptica |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053734D0 NO20053734D0 (no) | 2005-08-03 |
NO20053734L true NO20053734L (no) | 2005-10-26 |
Family
ID=32825327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053734A NO20053734L (no) | 2003-01-29 | 2005-08-03 | Hundevaksine mor Bordetella Bronchiseptica. |
Country Status (21)
Country | Link |
---|---|
US (2) | US20040185062A1 (no) |
EP (1) | EP1592444B1 (no) |
JP (3) | JP2006515024A (no) |
KR (1) | KR20050103215A (no) |
CN (1) | CN1835767A (no) |
AR (1) | AR042935A1 (no) |
AT (1) | ATE395077T1 (no) |
AU (1) | AU2004208556B2 (no) |
BR (1) | BRPI0407032A (no) |
CA (1) | CA2513352C (no) |
DE (1) | DE602004013723D1 (no) |
ES (1) | ES2303046T3 (no) |
HR (1) | HRP20050660A2 (no) |
MX (1) | MXPA05008051A (no) |
NO (1) | NO20053734L (no) |
PL (1) | PL378001A1 (no) |
RU (1) | RU2005124130A (no) |
TW (1) | TW200505476A (no) |
UY (1) | UY28171A1 (no) |
WO (1) | WO2004067031A1 (no) |
ZA (1) | ZA200506073B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
JP5393978B2 (ja) * | 2004-04-05 | 2014-01-22 | ゾエティス・ピー・エルエルシー | マイクロ流動化された水中油型乳剤及びワクチン組成物 |
EP1871410A2 (en) * | 2005-04-07 | 2008-01-02 | Pharmacia & Upjohn Company LLC | Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
BRPI0603490B1 (pt) * | 2006-07-21 | 2018-04-24 | Universidade Federal De Minas Gerais | Vacina recombinante contra a leishmaniose visceral canina |
EP2377550B1 (en) * | 2006-09-11 | 2015-03-04 | Zoetis P LLC | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
NZ577855A (en) | 2006-12-27 | 2012-07-27 | Pfizer Prod Inc | Vaccination schedule to prevent canine disease |
PL2134742T3 (pl) * | 2007-02-27 | 2012-10-31 | Zoetis Services Llc | Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt |
ES2728949T3 (es) * | 2008-06-27 | 2019-10-29 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
BR112012008861A2 (pt) * | 2009-10-14 | 2019-09-24 | Univ Oklahoma State | parvovírus, vacina, ácido nucleico isolado, composição imunogênica, método para provocar uma resposta imune em um animal contra a infecção por parvovírus, proteína vp-2 de parvovírus purificada, vetor de expressão, e método para exterminar células tumorais em um mamífero. |
US9381241B2 (en) * | 2010-09-28 | 2016-07-05 | Kyoritsu Seiyaku Corporation | Mucosal adjuvant composition |
CA2821422C (en) * | 2010-12-22 | 2024-01-02 | Intervet International B.V. | Vaccines comprising live aro mutant bordetella bronchiseptica |
RU2553222C2 (ru) * | 2011-02-04 | 2015-06-10 | ЗОИТИС ЭлЭлСи | Композиции для лечения и предупреждения комплекса респираторных заболеваний собак |
EP3858381A1 (en) * | 2011-02-04 | 2021-08-04 | Zoetis Services LLC | Immunogenic bordetella bronchiseptica compositions |
JP6313752B2 (ja) | 2012-05-31 | 2018-04-18 | ゾエティス・エルエルシー | B.ブロンキセプチカ(B.Bronchiseptica)感染から保護するためのイヌ呼吸器コロナウイルスでのワクチン接種 |
CZ307883B6 (cs) * | 2013-01-29 | 2019-07-24 | Bioveta, A.S. | Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů |
AU2014321369B2 (en) | 2013-09-19 | 2020-04-16 | Zoetis Services Llc | Oil-based adjuvants |
WO2016115456A1 (en) | 2015-01-16 | 2016-07-21 | Zoetis Services Llc | Foot-and-mouth disease vaccine |
CN107249629A (zh) * | 2015-02-26 | 2017-10-13 | 生控基因疫苗股份有限公司 | 包含免疫原性蛋白质及组合佐剂并用以诱发抗原特异性t细胞反应的疫苗组合物 |
CN106399260B (zh) * | 2015-07-31 | 2021-03-02 | 北京大北农科技集团股份有限公司动物医学研究中心 | 一种犬瘟热、细小病毒病二联活疫苗及其制备方法 |
TW202206098A (zh) * | 2020-08-11 | 2022-02-16 | 美商碩騰服務公司 | 抗冠狀病毒疫苗 |
IT202100014747A1 (it) * | 2021-06-07 | 2022-12-07 | Consiglio Nazionale Ricerche | Derivati sterolici come nuovi ligandi del recettore dectina-1 nel trattamento terapeutico di patologie correlate a tale recettore |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950512A (en) * | 1972-07-25 | 1976-04-13 | Pitman-Moore, Inc. | Animal vaccines |
GB2048669A (en) * | 1979-05-18 | 1980-12-17 | Moskov Nii Virusnykh Preparato | Canine distemper vaccines |
US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
GB8502399D0 (en) * | 1985-01-31 | 1985-03-06 | Akzo Nv | Canine parvovirus vaccines |
NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
DK0465204T3 (da) * | 1990-07-06 | 2000-10-09 | American Home Prod | Vaccine mod Lyme sygdom |
GB9106568D0 (en) * | 1991-03-27 | 1991-05-15 | Wellcome Found | Recombinant antigen |
ZA927037B (en) * | 1991-09-30 | 1993-03-29 | Akzo Nv | Respiratory disease vaccine for cats. |
JP2521226B2 (ja) * | 1993-01-28 | 1996-08-07 | 株式会社微生物化学研究所 | 犬用多種混合ワクチン |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
AUPO517897A0 (en) * | 1997-02-19 | 1997-04-11 | Csl Limited | Chelating immunostimulating complexes |
GB9718901D0 (en) * | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
-
2004
- 2004-01-15 JP JP2005518725A patent/JP2006515024A/ja not_active Withdrawn
- 2004-01-15 BR BR0407032-1A patent/BRPI0407032A/pt not_active IP Right Cessation
- 2004-01-15 DE DE602004013723T patent/DE602004013723D1/de not_active Expired - Lifetime
- 2004-01-15 AU AU2004208556A patent/AU2004208556B2/en not_active Expired
- 2004-01-15 WO PCT/IB2004/000146 patent/WO2004067031A1/en active IP Right Grant
- 2004-01-15 RU RU2005124130/15A patent/RU2005124130A/ru not_active Application Discontinuation
- 2004-01-15 CN CNA2004800030872A patent/CN1835767A/zh active Pending
- 2004-01-15 KR KR1020057014122A patent/KR20050103215A/ko not_active Application Discontinuation
- 2004-01-15 MX MXPA05008051A patent/MXPA05008051A/es not_active Application Discontinuation
- 2004-01-15 CA CA2513352A patent/CA2513352C/en not_active Expired - Lifetime
- 2004-01-15 AT AT04702384T patent/ATE395077T1/de not_active IP Right Cessation
- 2004-01-15 PL PL378001A patent/PL378001A1/pl not_active Application Discontinuation
- 2004-01-15 ES ES04702384T patent/ES2303046T3/es not_active Expired - Lifetime
- 2004-01-15 EP EP04702384A patent/EP1592444B1/en not_active Expired - Lifetime
- 2004-01-27 AR ARP040100232A patent/AR042935A1/es unknown
- 2004-01-28 TW TW093101852A patent/TW200505476A/zh unknown
- 2004-01-28 UY UY28171A patent/UY28171A1/es not_active Application Discontinuation
- 2004-01-29 US US10/767,809 patent/US20040185062A1/en not_active Abandoned
-
2005
- 2005-07-19 HR HR20050660A patent/HRP20050660A2/hr not_active Application Discontinuation
- 2005-07-28 ZA ZA200506073A patent/ZA200506073B/en unknown
- 2005-08-03 NO NO20053734A patent/NO20053734L/no unknown
-
2006
- 2006-12-20 JP JP2006342944A patent/JP5319882B2/ja not_active Expired - Lifetime
-
2007
- 2007-11-20 US US11/942,843 patent/US7736658B2/en not_active Expired - Lifetime
-
2011
- 2011-02-17 JP JP2011031652A patent/JP2011137017A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1835767A (zh) | 2006-09-20 |
HRP20050660A2 (en) | 2006-02-28 |
NO20053734D0 (no) | 2005-08-03 |
EP1592444B1 (en) | 2008-05-14 |
MXPA05008051A (es) | 2005-09-21 |
US20040185062A1 (en) | 2004-09-23 |
ZA200506073B (en) | 2006-05-31 |
TW200505476A (en) | 2005-02-16 |
CA2513352C (en) | 2010-10-12 |
EP1592444A1 (en) | 2005-11-09 |
DE602004013723D1 (de) | 2008-06-26 |
JP2007161718A (ja) | 2007-06-28 |
KR20050103215A (ko) | 2005-10-27 |
ATE395077T1 (de) | 2008-05-15 |
AU2004208556A1 (en) | 2004-08-12 |
CA2513352A1 (en) | 2004-08-12 |
JP2011137017A (ja) | 2011-07-14 |
US7736658B2 (en) | 2010-06-15 |
PL378001A1 (pl) | 2006-02-20 |
JP2006515024A (ja) | 2006-05-18 |
RU2005124130A (ru) | 2006-01-20 |
WO2004067031A1 (en) | 2004-08-12 |
AU2004208556B2 (en) | 2009-06-04 |
JP5319882B2 (ja) | 2013-10-16 |
AR042935A1 (es) | 2005-07-06 |
ES2303046T3 (es) | 2008-08-01 |
BRPI0407032A (pt) | 2006-01-17 |
US20080226670A1 (en) | 2008-09-18 |
UY28171A1 (es) | 2004-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053734L (no) | Hundevaksine mor Bordetella Bronchiseptica. | |
NO20071385L (no) | Multivalent hundevaksine mot leptospira Bratislava og andre patogener | |
AR064530A1 (es) | Procedimientos para la administracion de vacunas | |
HRP20050192B1 (hr) | Cjepivo za infekcije dišnog i spolnog sustava kod goveda | |
EP0988051A4 (en) | COMBINATION COMPOSITIONS FOR LYME DISEASE AND APPLICATIONS | |
AR043892A1 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
RU2009120894A (ru) | Вакцина против лаймской болезни собак | |
TH71070A (th) | วัคซีนสุนัขต้าน Bordetella bronchiseptica | |
RU2006133328A (ru) | Способ вакцинации против инфекции семенников bvdv | |
RU2020120941A (ru) | Вакцина против болезни лайма у собак | |
Ford | Shelter medicine infectious disease threats-canine. | |
AR045152A1 (es) | Vacunas virales mutantes | |
UA32966U (ru) | Вакцина против лептоспироза животных поливалентная (вариант suis) |